Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02881086
Title Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Goethe University
Indications

T-cell acute lymphoblastic leukemia

B-cell acute lymphoblastic leukemia

acute lymphoblastic leukemia

Therapies

Rituximab

Doxorubicin

Cytarabine

Mercaptopurine

Nelarabine

Methotrexate

Pegaspargase

Cyclophosphamide

Vindesine

Vincristine Sulfate

Daunorubicin

Dexamethasone

Age Groups: adult | senior
Covered Countries


No variant requirements are available.